These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 31897700)

  • 1. [Cannabidiol in cancer treatment].
    Likar R; Köstenberger M; Nahler G
    Schmerz; 2020 Apr; 34(2):117-122. PubMed ID: 31897700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics.
    Nahler G
    Pharmaceut Med; 2022 Apr; 36(2):99-129. PubMed ID: 35244889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).
    Hardy J; Haywood A; Gogna G; Martin J; Yates P; Greer R; Good P
    Trials; 2020 Jul; 21(1):611. PubMed ID: 32631447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homegrown perceptions about the medical use and potential abuse of CBD and THC.
    McFadden BR; Malone T
    Addict Behav; 2021 Apr; 115():106799. PubMed ID: 33387977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome.
    Al-Ghezi ZZ; Busbee PB; Alghetaa H; Nagarkatti PS; Nagarkatti M
    Brain Behav Immun; 2019 Nov; 82():25-35. PubMed ID: 31356922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration.
    Liu Z; Galettis P; Broyd SJ; van Hell H; Greenwood LM; de Krey P; Steigler A; Zhu X; Schneider J; Solowij N; Martin JH
    Intern Med J; 2020 Jul; 50(7):846-853. PubMed ID: 31264294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical uses of cannabis and cannabinoids in the United States.
    Levinsohn EA; Hill KP
    J Neurol Sci; 2020 Apr; 411():116717. PubMed ID: 32044684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of cannabis in supportive care and treatment of brain tumor.
    Likar R; Nahler G
    Neurooncol Pract; 2017 Sep; 4(3):151-160. PubMed ID: 31385997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Critical Review of the Role of the Cannabinoid Compounds Δ
    Jones É; Vlachou S
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging challenges in the extraction, analysis and bioanalysis of cannabidiol and related compounds.
    Brighenti V; Protti M; Anceschi L; Zanardi C; Mercolini L; Pellati F
    J Pharm Biomed Anal; 2021 Jan; 192():113633. PubMed ID: 33039911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis, cannabidiol and tetrahydrocannabinol in sport: an overview.
    Kennedy M
    Intern Med J; 2022 Sep; 52(9):1471-1477. PubMed ID: 35191178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis sativa: Much more beyond Δ
    Alves P; Amaral C; Teixeira N; Correia-da-Silva G
    Pharmacol Res; 2020 Jul; 157():104822. PubMed ID: 32335286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constituents of Cannabis Sativa.
    Rock EM; Parker LA
    Adv Exp Med Biol; 2021; 1264():1-13. PubMed ID: 33332000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
    Mead A
    Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. THC and CBD effects on alcohol use among alcohol and cannabis co-users.
    Karoly HC; Mueller RL; Andrade CC; Hutchison KE
    Psychol Addict Behav; 2021 Sep; 35(6):749-759. PubMed ID: 33764086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Consequences of Adolescent Exposure to THC-Rich/CBD-Poor and CBD-Rich/THC-Poor Combinations: A Comparison with Pure THC Treatment in Female Rats.
    Gabaglio M; Zamberletti E; Manenti C; Parolaro D; Rubino T
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis constituents reduce seizure behavior in chemically-induced and scn1a-mutant zebrafish.
    Thornton C; Dickson KE; Carty DR; Ashpole NM; Willett KL
    Epilepsy Behav; 2020 Sep; 110():107152. PubMed ID: 32585475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential.
    Ashton CH; Moore PB; Gallagher P; Young AH
    J Psychopharmacol; 2005 May; 19(3):293-300. PubMed ID: 15888515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.